Five biotech buyout candidates you should look at right now By: MarketWatch January 24, 2018 at 05:51 AM EST Jeff Reeves looks at five biotechs that might be buyout candidates in the wake of the big Juno deal. Read More >> Related Stocks: Acadia Pharmaceutica Biomarin Pharmaceuticals Bluebird Bio Cara Therapeutics Celgene Corp Eli Lilly Incyte Corp Merus N.V. CS Nasdaq Biotechnology Ishares ETF S&P Biotech SPDR